Supernus Pharmaceuticals, Inc.

Hillsdale Investment Management Inc. SUPN

Report date

6/30/2026

Quarter

2026 Q2

Filed

8/12/2026

Shares

103,680

Value ($000)

4,822

Weight

0.1%

2025 Q1 - 2026 Q2 (2 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q2	8/12/2026	4,822	0.1%	103,680	6/30/2026
2025 Q1	5/9/2025	6	0.0%	180	3/31/2025